# Dispensing Evaluation of Subjective Comfort, Vision, and Handling of a New Lens Compared to a Marketed Lens

> **NCT01484054** · NA · COMPLETED · sponsor: **Johnson & Johnson Vision Care, Inc.** · enrollment: 103 (actual)

## Conditions studied

- Refractive Ametropia

## Interventions

- **DEVICE:** etafilcon A with print and PVP for dark eyes (EAPVPDE)
- **DEVICE:** etafilcon A control lens (EADE)

## Key facts

- **NCT ID:** NCT01484054
- **Lead sponsor:** Johnson & Johnson Vision Care, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2012-02
- **Final completion:** 2012-02
- **Target enrollment:** 103 (ACTUAL)
- **Last updated:** 2018-06-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01484054

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01484054, "Dispensing Evaluation of Subjective Comfort, Vision, and Handling of a New Lens Compared to a Marketed Lens". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT01484054. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*